Data di Pubblicazione:
2022
Citazione:
Progress in prostate cancer prevention / G. Cozzi, G. Musi, M. Ferro, A. Cioffi, O. de Cobelli, G. Corso. - In: EUROPEAN JOURNAL OF CANCER PREVENTION. - ISSN 0959-8278. - 31:6(2022 Nov 01), pp. 554-557. [10.1097/CEJ.0000000000000745]
Abstract:
After lung, prostate cancer is the second most frequently diagnosed cancer and fourth in cancer-related mortality. The etiology is largely unknown and no clear risk factors have been identified. Primary prevention is therefore challenging. Also, secondary prevention, screening, in large populations is difficult. Germline mutations are implicated in hereditary prostate cancer, accounting for about 10% of screened men. Currently, only prostate-specific antigen test is adopted for early detection but is considered insufficient to further improve prevention and care. In this opinion article, we discuss novel diagnostic biomarkers and imaging tools, along with more promising targeted prostate biopsies.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
prostate cancer; prostate specific antigen; imaging tools genetics
Elenco autori:
G. Cozzi, G. Musi, M. Ferro, A. Cioffi, O. de Cobelli, G. Corso
Link alla scheda completa: